The Cigna Group (CI) Goldman Sachs 45th Annual Global Healthcare Conference summary

Financial performance and guidance

• Reaffirmed full-year EPS outlook of at least $28.40, raised by $0.15 after a strong first quarter.

• Capital deployment focused on share repurchases, with $4.4B completed year-to-date and at least $5B targeted for the first half.

• Majority of full-year capital available will be used for share repurchases, including proceeds from the pending Medicare divestiture.

• No significant surprises in Q2; cost trends and utilization are tracking as expected.

• Medical care ratio seasonality expected to return to pre-pandemic norms, with a step up from Q1 to Q2.

Utilization and cost trends

• Elevated inpatient activity expected to persist throughout 2024; outpatient trends impacted by prior disruptions but normalizing.

• Mental health utilization remains high, contributing to overall cost trends.

• No significant deviations in utilization across business lines in Q2.

• Change Healthcare disruption reserves are being resolved, with operations back to normal.

Segment and market strategy

• Pricing remains rational and competitive, with carriers adjusting for elevated cost trends.

• National accounts seeing increased RFP activity for 2025, with demand for personalized solutions and integrated capabilities.

• Select segment (50-500 employees) targeted for outsized growth, aiming to double revenue over five years.

• Cost competitiveness and flexible funding arrangements are key differentiators in the select segment.